Targeting the TREK-1 potassium channel via riluzole to eliminate the neuropathic and depressive-like effects of oxaliplatin

Laura Poupon, Sylvain Lamoine, Vanessa Pereira, David André Barrière, Stéphane Lolignier, Fabrice Giraudet, Youssef Aissouni, Mathieu Méleine, Laëtitia Prival, Damien Richard,

Neuropharmacology · 2018 · 68 citations · 59 references

DOIFull text

Open access

Concepts

References

59